Solifenacin

Results: 23



#Item
1

Vecchioli-Scaldazza C. · Morosetti C. · Berouz A. · Giannubilo W. · Ferrara V. Solifenacin Succinate versus Percutaneous Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Results of a Randomized Con

Add to Reading List

Source URL: www.sunmedical.it

Language: English - Date: 2013-04-02 08:42:02
    2

    solifenacin succinate compared to tolterodine tolterodine l-tartrate 4mg. tolterodine l-tartrate tolterodine base, enablex vs tolterodine la tolterodine, medcine tolterodine, tolterodine 4 mg, comparison of fesoterodine

    Add to Reading List

    Source URL: www.naturaldiamondcompany.com

    Language: English - Date: 2016-06-17 03:28:50
      3Organic chemistry / Neurochemistry / Tolterodine / Solifenacin / Fesoterodine / Zolpidem / Alprazolam / Tartrate / Methylprednisolone / Muscarinic antagonists / Chemistry / Pfizer

      opera manuscript tolterodine. comparison of fesoterodine and tolterodine medrol dose pack tolterodine tolterodine conversion, tolterodine effects on potassium levels tolterodine excipients tolterodine xl, tolterodine tol

      Add to Reading List

      Source URL: novasom.com

      Language: English - Date: 2015-07-20 07:46:43
      4

      Coll. Antropol: 243–248 Original scientific paper The Efficacy and Safety of Solifenacin in Patients with Overactive Bladder Syndrome Slavko Ore{kovi}1, Igor But2, Maja Banovi}1 and Marina [prem Gold{tajn1

      Add to Reading List

      Source URL: medlib.mef.hr

      Language: English - Date: 2012-08-07 05:50:33
        5

        Omprövning av Toviaz, Vesicare och Emselex vid trängningsinkontinens Oktober 2014 Sammanfattning • Toviaz (fesoterodin) och Vesicare (solifenacin) kvarstår i

        Add to Reading List

        Source URL: www.tlv.se

        Language: Swedish - Date: 2014-10-07 07:52:21
          6

          VESICARE ® 5 mg en 10 mg solifenacin succinate Tablets Astellas

          Add to Reading List

          Source URL: db.cbg-meb.nl

          Language: Dutch - Date: 2014-02-12 07:22:40
            7Medicine / Overactive bladder / Solifenacin / Urinary incontinence / Urinary retention / Percutaneous tibial nerve stimulation / Duloxetine / Muscarinic antagonists / Chemistry / Organic chemistry

            Media Contact: Christy Nolandofficemobile) Investor Contact:

            Add to Reading List

            Source URL: www.astellas.com

            Language: English - Date: 2015-05-17 18:16:46
            8Tacrolimus / Tamsulosin / Micafungin / Solifenacin / FARMA / Chemistry / Organic chemistry / Astellas Pharma

            15 June, 2010 Press Release Astellas’ Brazilian Affiliate Initiates Business Operations Japan, June 15, [removed]Astellas Pharma Inc. (headquarters: Tokyo, president and CEO:

            Add to Reading List

            Source URL: www.astellas.com

            Language: English - Date: 2010-06-14 23:37:40
            9Incontinence / Overactive bladder / Muscarinic antagonists / Solifenacin / Urge incontinence / Astellas Pharma / Frequent urination / Urinary bladder / Benign prostatic hyperplasia / Medicine / Urology / Anatomy

            Astellas Obtained Approval for Vesicare OD in Japan Tokyo, October 27, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it obtained the approval of ma

            Add to Reading List

            Source URL: www.astellas.com

            Language: English - Date: 2010-10-26 22:39:57
            10Incontinence / Overactive bladder / Muscarinic antagonists / Solifenacin / Astellas Pharma / Urinary incontinence / Urge incontinence / Urinary bladder / Frequent urination / Medicine / Urology / Anatomy

            June 1, 2006 Astellas Launches “Vesicare®” for the treatment of Overactive Bladder in Japan Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Toichi Takenaka) today announced that Vesicar

            Add to Reading List

            Source URL: www.astellas.com

            Language: English - Date: 2008-09-19 00:56:17
            UPDATE